Group One Trading’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.5M | Sell |
393,200
-51,900
| -12% | -$2.69M | 0.04% | 407 |
|
|
2026
Q1 | $22.6M | Sell |
445,100
-30,200
| -6% | -$1.41M | 0.04% | 426 |
|
|
2025
Q4 | $14M | Sell |
475,300
-72,600
| -13% | -$1.97M | 0.02% | 739 |
|
|
2025
Q3 | $14.2M | Buy |
547,900
+138,600
| +34% | +$3.87M | 0.02% | 697 |
|
|
2025
Q2 | $11.3M | Sell |
409,300
-16,900
| -4% | -$445K | 0.03% | 735 |
|
|
2025
Q1 | $12.1M | Buy |
426,200
+151,700
| +55% | +$5.38M | 0.04% | 541 |
|
|
2024
Q4 | $11.4M | Sell |
274,500
-61,400
| -18% | -$2.93M | 0.03% | 628 |
|
|
2024
Q3 | $22.4M | Buy |
335,900
+172,100
| +105% | +$15.8M | 0.06% | 245 |
|
|
2024
Q2 | $19.5M | Buy |
163,800
+46,900
| +40% | +$5.94M | 0.08% | 210 |
|
|
2024
Q1 | $12.5M | Buy |
116,900
+1,200
| +1% | +$121K | 0.05% | 349 |
|
|
2023
Q4 | $11.5M | Sell |
115,700
-62,500
| -35% | -$5.26M | 0.03% | 623 |
|
|
2023
Q3 | $18.4M | Sell |
178,200
-42,500
| -19% | -$4.74M | 0.06% | 257 |
|
|
2023
Q2 | $26.8M | Buy |
220,700
+48,400
| +28% | +$6.46M | 0.09% | 164 |
|
|
2023
Q1 | $26.5M | Sell |
172,300
-473,200
| -73% | -$78.1M | 0.1% | 154 |
|
|
2022
Q4 | $116M | Buy |
645,500
+170,100
| +36% | +$27.8M | 0.27% | 47 |
|
|
2022
Q3 | $56.2M | Sell |
475,400
-288,100
| -38% | -$43.7M | 0.11% | 119 |
|
|
2022
Q2 | $109M | Sell |
763,500
-338,200
| -31% | -$48.3M | 0.17% | 62 |
|
|
2022
Q1 | $190M | Sell |
1,101,700
-214,100
| -16% | -$36M | 0.19% | 53 |
|
|
2021
Q4 | $334M | Sell |
1,315,800
-266,200
| -17% | -$77.8M | 0.27% | 36 |
|
|
2021
Q3 | $609M | Buy |
1,582,000
+774,100
| +96% | +$285M | 0.66% | 12 |
|
|
2021
Q2 | $190M | Buy |
807,900
+77,100
| +11% | +$13.8M | 0.23% | 49 |
|
|
2021
Q1 | $95.7M | Sell |
730,800
-11,900
| -2% | -$1.72M | 0.14% | 95 |
|
|
2020
Q4 | $77.6M | Buy |
742,700
+102,100
| +16% | +$10.3M | 0.13% | 100 |
|
|
2020
Q3 | $45.3M | Buy |
640,600
+167,800
| +35% | +$11.7M | 0.14% | 107 |
|
|
2020
Q2 | $30.4M | Sell |
472,800
-239,700
| -34% | -$13.1M | 0.14% | 128 |
|
|
2020
Q1 | $21.3M | Buy |
712,500
+579,900
| +437% | +$13.3M | 0.17% | 88 |
|
|
2019
Q4 | $2.59M | Sell |
132,600
-14,600
| -10% | -$259K | 0.02% | 1095 |
|
|
2019
Q3 | $2.34M | Buy |
147,200
+78,400
| +114% | +$1.16M | 0.02% | 1084 |
|
|
2019
Q2 | $1.01M | Buy |
68,800
+67,000
| +3,722% | +$1.44M | 0.01% | 1586 |
|
|
2019
Q1 | $37K | Buy |
+1,800
| New | +$33.4K | ﹤0.01% | 3720 |
|
Other funds holding MRNA
TP
Group One Trading's MRNA Position: Q2 2026 in Review
Group One Trading increased its Moderna (MRNA) stake by 326% in Q2 2026, buying an estimated $8.07M and bringing the position to 203,915 shares worth $14.3M. The position accounts for 0.02% of the portfolio, ranked #742.
Group One Trading first reported a position in MRNA in Q4 2018 and has held it in 26 quarters since. The position peaked at $37.3M in Q4 2022. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Group One Trading held 203,915 shares of Moderna worth $14.3M as of Q2 2026.
- Group One Trading bought 156,014 Moderna shares in Q2 2026, an estimated $8.07M.
- Moderna made up 0.02% of Group One Trading's portfolio in Q2 2026, its #742 holding.
- Group One Trading first reported a position in Moderna in Q4 2018 and has held it in 26 quarters since.
- Group One Trading's Moderna position peaked at $37.3M in Q4 2022.
- 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.